Testing for the new normal

COVID-19 has transformed the healthcare world, and decontamination in particular. We all have to get used to the ‘new normal’ where every surface is a potential vector of transmission. Before the pandemic, hospitals might source products first, then consider how to decontaminate them. But now, that’s no longer enough. Instead, manufacturers need to integrate decontamination into their product-development processes. That way, they can ensure that even newly launched products have proven compatibility with the main cleaning and decontamination technologies, and come complete with ready-to-use decontamination protocols.

On top of that, the pandemic has imposed a huge extra burden on both commercial and government testing facilities, and any future outbreaks can only make things worse. Even in adverse circumstances manufacturers still need to test their products, especially if those products are part of a pandemic or crisis response.

Overall, no matter how high our standards were before, they now have to be higher. Hospitals and manufacturers must work together to keep infection rates as low as possible.

That's where we come in